Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Healthcare Biotechnology
Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Lattice Biologics Ltd > IMPORTANT! BE CAREFUL!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(8)
•••
Comment by Accept2on May 22, 2020 8:32pm
87 Views
Post# 31063459

RE:RE:RE:IMPORTANT! BE CAREFUL!

RE:RE:RE:IMPORTANT! BE CAREFUL!Quick question since you seem to think everything in business is so simple with your "model."....Which of your 2 fantasy people (?companies?) is The Fed? Just thought I would ask before your simplified Universe imploded on itself. How does its management fare in your Michelin Guide? What about General Mistake? IBM? Lookin good McCoy!........
 

gainwidpatience wrote: There are 2 kind of people who runs the race.. one who run to win and second one is to only participate without any ambition to win. The way LBL's communication to shareholders (highlighting risk, competitors, etc), unnecessary comments to shareholders (Guy's advice to invest in etf's, fixed income) and poor planning (no collaboration for getting patients, clinical trials, not applying for grants, etc.).. proved enough that they belong to category 2.

i had a bid @0.055 today for adding more, decided to drop it after 15 mins when I saw those mighty asks!

However, I still believe that AmnioBoost will make wonders.. but unfortunately it's in the hands of wrong management!

Again.. I will chose to wait here.. but it's definitely a lesson learnt here.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities